MedTrace Logo

Evaluation of Amniotic Fluid Product in Knee Osteoarthritis

NCT02768155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-26

No results posted yet for this study

Summary

A study evaluating Amniotic Fluid compared to a Saline Placebo Injection in the treatment of subjects with osteoarthritic (OA) knee pain

Conditions

  • Osteoarthritis of the Knee

Interventions

OTHER

Amniotic Fluid 4.0ml dose

Injection of Amniotic Fluid

OTHER

Amniotic Fluid 2.0ml dose

Injection of Amniotic Fluid

OTHER

Placebo Control

Normal Saline

Sponsors & Collaborators

  • MiMedx Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Donald Fetterolf, MD · MiMedx Group, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02768155 on ClinicalTrials.gov